Long-term efficacy of ibrutinib-venetoclax for first-line treatment in chronic lymphocytic leukaemia.

Lancet Oncol

Department I of Internal Medicine, University of Cologne, 50937 Cologne, Germany. Electronic address:

Published: December 2023

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(23)00485-0DOI Listing

Publication Analysis

Top Keywords

long-term efficacy
4
efficacy ibrutinib-venetoclax
4
ibrutinib-venetoclax first-line
4
first-line treatment
4
treatment chronic
4
chronic lymphocytic
4
lymphocytic leukaemia
4
long-term
1
ibrutinib-venetoclax
1
first-line
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!